Die Erfindung betrifft thermoplastische Formmassen auf Basis von Polyamiden und/oder Polyestern sowie spezieller, funktionell modifizierter Polyarylensulfide und gegebenenfalls üblicher Zusatzstoffe, ihre Herstellung und ihre Verwendung.
申请人:Radopath Pharmaceuticals International Limited
公开号:EP1016405A2
公开(公告)日:2000-07-05
Various arylating agents having activity in the treatment of cancer and viral infection are disclosed. The active compounds include an aromatic ring having at least one labile leaving group and at least one electrophilic group. Preferred active compounds include chlorobenzenesulphonic acids and optionally halogenated nitrobenzenc compounds. In an anti-viral context, the active compounds have efficacy against HIV infections.